Genomic Rearrangement Signatures and Clinical Outcomes in High-Grade Serous Ovarian Cancer

Hillman R. Tyler; Chisholm Gary B.; Lu Karen H.; Futreal P. Andrew

首页> 外文期刊>Journal of the National Cancer Institute >Genomic Rearrangement Signatures and Clinical Outcomes in High-Grade Serous Ovarian Cancer

【24h】

Genomic Rearrangement Signatures and Clinical Outcomes in High-Grade Serous Ovarian Cancer

机译：高级浆液癌中的基因组重排签名及临床结果

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: To identify clinically relevant genomic rearrangement signatures in high-grade serous ovarian cancer (HGSOC), we conducted a retrospective analysis of sequenced HGSOC whole-tumor genomes.

机译：背景：为了鉴定高级浆液卵巢癌（HGSOC）的临床相关基因组重排签，我们对测序的HGSOC全肿瘤基因组进行了回顾性分析。

著录项

来源
《Journal of the National Cancer Institute》 |2018年第3期|共8页
作者
Hillman R. Tyler; Chisholm Gary B.; Lu Karen H.; Futreal P. Andrew;
展开▼
作者单位

Univ Texas MD Anderson Canc Ctr Dept Gynecol Oncol &

Reprod Med Houston TX 77030 USA;

Univ Texas MD Anderson Canc Ctr Dept Gynecol Oncol &

Reprod Med Houston TX 77030 USA;

Univ Texas MD Anderson Canc Ctr Dept Gynecol Oncol &

Reprod Med Houston TX 77030 USA;

Univ Texas MD Anderson Canc Ctr Dept Genom Med Houston TX 77030 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Genomic Rearrangement Signatures and Clinical Outcomes in High-Grade Serous Ovarian Cancer [J] . Hillman R. Tyler, Chisholm Gary B., Lu Karen H., Journal of the National Cancer Institute . 2018,第3期

机译：高级浆液癌中的基因组重排签名及临床结果
2. Glycoproteomics-based signatures for tumor subtyping and clinical outcome prediction of high-grade serous ovarian cancer [J] . Jianbo Pan, Yingwei Hu, Shisheng Sun, Nature Communications . 2020,第1期

机译：基于糖蛋白质的肿瘤亚型签名和高级浆液癌的临床结果预测
3. A 2-Protein Signature Predicting Clinical Outcome in High-Grade Serous Ovarian Cancer [J] . Jin Chengjuan, Xue Yingfeng, Li Yingwei, International journal of gynecological cancer: official journal of the International Gynecological Cancer Society . 2018,第1期

机译：预测高级浆液癌临床结果的2蛋白签名
4. Global proteomic analysis of ovarian high-grade serous carcinomas using SWATH-MS for targeted verification of proteome changes associated with genomic alterations [C] . Stefani N. Thomas, Jing Chen, Paul Aiyetan, ASMS Conference on Mass Spectrometry and Allied Topics . 2015

机译：卵巢高级浆液癌的全局蛋白质组学分析使用SWATH-MS进行靶向验证与基因组改变相关的蛋白质组变化
5. Characterization of Precancerous Mutations in Ulcerative Colitis-Associated Colorectal Cancer and High-Grade Serous Ovarian Cancer via Duplex Sequencing [D] . Baker, Kathryn Terese 2018

机译：溃疡性结肠炎相关大肠癌和高级别浆液性卵巢癌癌前突变的双重测序表征。
6. Genomic Rearrangement Signatures and Clinical Outcomes in High-Grade Serous Ovarian Cancer [O] . R Tyler Hillman, Gary B Chisholm, Karen H Lu, -1

机译：高级别浆液性卵巢癌的基因组重排特征和临床结果
7. Glycoproteomics-based signatures for tumor subtyping and clinical outcome prediction of high-grade serous ovarian cancer [O] . Jianbo Pan, Yingwei Hu, Shisheng Sun, 2020

机译：基于糖蛋白质的肿瘤亚型签名和高级浆液癌的临床结果预测

Genomic Rearrangement Signatures and Clinical Outcomes in High-Grade Serous Ovarian Cancer

摘要

著录项

相似文献

相关主题

期刊订阅